Biomarin Pharmaceutical Inc (BMRN)
65.69
+0.69
(+1.06%)
USD |
NASDAQ |
Dec 20, 16:00
65.65
-0.04
(-0.06%)
After-Hours: 20:00
Biomarin Pharmaceutical Shareholders Equity (Quarterly): 5.413B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co Inc | 44.50B |
| Biogen Inc | 16.36B |
| Pfizer Inc | 92.29B |
| Bristol-Myers Squibb Co | 17.14B |
| Moderna Inc | 11.93B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.851B |
| Total Liabilities (Quarterly) | 1.438B |
| Debt to Equity Ratio | 0.1098 |
| Current Ratio | 4.271 |
| Net Debt Paydown Yield | 0.73% |